1933 INDUSTRIES WKN: A2N61A ISIN: CA65442F1053 Kürzel: 1QF Forum: Aktien Thema: Hauptdiskussion

Lol 2023 wird erst das Verbot aufgehoben

https://www.clearstream.com/clearstream-en/keydocuments-1-/csd-1-/referencedata/cannabis-related-securities-1385390

😑

😑

um wieder liquide zu sein

Mit der Option sie zurück zu kaufen

Wieso baut man eine grow Anlage und verkauft sie dann wieder

Was heißt das jetzt haben die jetzt was gekauft oder verkauft

1933 Industries gibt den Verkauf seines Kultivierungsimmobilienvermögens in Las Vegas im Wert von 10,45 Mio. USD mit einem 10-jährigen Lease-Back bekannt Der Erlös aus dem Verkauf Bilanz stärken und nicht-verwässernde Kapital für die Expansion Initiativen entsperren 1933 Industries freut sich bekannt zu geben, dass seine Tochtergesellschaft, die Alternative Medicine Association („AMA“), einen Sale and Lease Back (die „Sale Transaction“) für ihre neu errichtete Cannabis-Anbauanlage in Las Vegas, Nevada, abgeschlossen hat. Der Kaufpreis für die Verkaufstransaktion beträgt USD 10.450.000, die das Unternehmen erhalten hat, vorbehaltlich einer Rückbehaltung von USD 500.000, die nach Abschluss der Einrichtung und Erteilung einer unbefristeten Nutzungserlaubnis freigegeben wird, und einer Rückbehaltung von USD 250.000, die freigegeben wird Ausgabe von staatlichen und lokalen für die Anlage ermöglicht. AMA rechnet Erhalt aller Genehmigungen und Zulassungen für die vollständigen Anbaumaßnahmen innerhalb von 45 Tagen. Die Verkaufstransaktion umfasst die Anbaufläche sowie das 1,39 Hektar große Grundstück, auf dem sie liegt. Die Verkaufstransaktion umfasst einen Lease-Back-Vertrag für einen Zeitraum von 10 Jahren mit der Option, die Leasingdauer um zwei weitere Zeiträume von jeweils 5 Jahren zu verlängern, um einen langfristigen Standort für den laufenden Anbau des Unternehmens zu gewährleisten. Das Unternehmen meldet auch, dass es eine befristete Aufenthaltserlaubnis für die Einrichtung erhalten hat.   Herr Brayden Sutton, President & CEO, sagte: „Wir freuen uns, die Verkaufstransaktion abzuschließen und unser Immobilienvermögen zu nutzen, um unser Wachstum zu unterstützen. Wir haben den Erwerb des Grundstücks und den Bau der Anlage ohne Verschuldung finanziert, sodass der gesamte Verkaufserlös für das Betriebskapital und zur Finanzierung von Akquisitionen in wichtigen Cannabismärkten zur Verfügung steht. Das sorgfältige Festhalten an einer effizienten Kapitalallokation und an soliden operativen Praktiken hat uns zu einer starken Finanzposition geführt, die uns in unsere nächste Wachstumsphase treiben wird. “

1933 Industries Announces USD$10.45 Million Sale of its Cultivation Real Estate Asset in Las Vegas with a 10-Year Lease-Back Proceeds of the sale strengthen balance sheet and unlock non-dilutive capital for expansion initiatives 1933 Industries is pleased to announce that its subsidiary, Alternative Medicine Association (“AMA”), has completed a sale and lease back (the “Sale Transaction”) for its newly constructed cannabis cultivation facility in Las Vegas, Nevada. The purchase price for the Sale Transaction is USD$10,450,000, which the Company has received, subject to a USD$500,000 hold back to be released upon the completion of the facility and issuance of permanent occupancy permits, and a USD$250,000 hold back to be released upon issuance of state and local permitting for the facility. AMA anticipates receipt of all permits and approvals for full cultivation operations within 45 days. The Sale Transaction includes the cultivation facility as well as the 1.39 acres of land it sits on. The Sale Transaction includes a lease-back agreement for a period of 10 years, with the option to extend the lease term for two additional periods of 5 years each, ensuring a long term location for the ongoing cultivation operations of the Company. The Company also reports that it has received a Temporary Occupancy Permit for the facility. Mr. Brayden Sutton, President & CEO, said “We are pleased to complete the Sale Transaction and leverage our real estate asset to support our growth. We funded the purchase of the land and construction of the facility without incurring any debt, so the full sale proceeds are available for working capital and to fund acquisitions in key cannabis markets. Our diligent adherence to efficient capital allocation and sound operational practices has led us to maintain a strong financial position which will propel us into our next growth stage”.

May 13, 2019 1933 Industries to Present at the 3rd Annual Canaccord Genuity Cannabis Conference and at the CannaStocks 2019 Q1 Investor Conference in New York this Week 1933 Industries Inc. is pleased to report that Mr. Chris Rebentisch, USA COO and Founder of the Company’s Infused MFG. subsidiary, will present to an investor audience this week in New York during two highly anticipated events in the cannabis industry. 3rd Annual Canaccord Genuity Cannabis Conference Held on May 14th at the Grand Hyatt New York, the one-day event will feature company presentations and one-on-one meetings with senior management teams representing every facet of the global cannabis industry, including U.S. multi-state operators, Canadian licensed producers, technology providers, brand owners and hemp producers from across North America, Europe, Australia and South America. Mr. Rebentisch’s formal presentation is scheduled for 9:20AM and the 1933 Industries team will be available for private meetings throughout the day. For more information, please visit https://www.canaccordgenuity.com/capital-markets/about-us/events/ CannaStocks2019 Q1 Investor Conference The Company will also present at the CannaStocks2019 Q1 Investor Conference to be held at the OTC Markets Group offices in New York on May 15th, featuring company presentations and discussions regarding current market trends from a few select OTC Markets QX and QB tier Issuers. Mr. Rebentisch is scheduled to present at 3:00PM. Industry participants will provide insight on themes including: innovation, consolidation, international expansion and specialization. For those investors unable to attend in person, a live streaming video webcast of the event will be available on the Virtual Investor Conferences, which will also be archived and *** available after the event. For more information, please visit www.CannaStocks2019.com About 1933 Industries Inc. 1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of Alternative Medicine Association and 100% of both Infused MFG. and Spire Global Strategy

I agree, since month we hear always what´s going on. The output is increasing, new facilities are, or will be build, but...……………..I´m loosing more and more money. Maybe someone can explain the strategy behind these statements. In any case, this is not recognizable in the share price.

Immer der gleiche scheis good News get down

1933 Industries to Increase Versatility and Output of Hemp Extraction Facility Investment in research and development will create a cutting edge hemp processing facility with increased output capacity and versatility to work with additional cannabinoids. 1933 Industries is pleased to provide an update regarding its new hemp extraction facility in Las Vegas, Nevada. Fully Customized Processing Facility and Equipment The Company announces that it is progressing with plans to launch one of Nevada’s largest hemp extraction facilities, become a major player in the booming CBD (cannabinoid) industry and add a new significant revenue stream to its business model. The Company, in collaboration with a leading engineering firm, has completed an extensive research and development phase to develop a customized design in order to provide for a larger, more efficient and more robust hemp processing laboratory (“Hemp Lab”) than originally planned. The Hemp Lab has been designed in *** with the new regulations and recommendations set out by the recently passed farm bill or Agricultural Improvement Act of 2018. Increased Capacity and Versatility The Company plans to deploy a custom-built, ethanol extraction system with full chromatography abilities to allow for isolation of THC, CBD, CBN, CBG, CBC, and several other cannabinoids, including the ability to produce full spectrum and broad spectrum oils, as well as isolates. The equipment is currently being engineered to meet required GMP standards. The Hemp Lab’s increased capacity is estimated at a maximum monthly throughput of 68,000 kgs. of hemp biomass, producing approximately 5,000 kgs. of full spectrum oils or 4,500 kgs. of CBD isolate. This is an increase in capacity greater than previously announced on December 20, 2018. Timing and Scope Once the equipment and new facility design is finalized and approved by the Clark County zoning department in Nevada, construction will commence on the building. Subsequently, the customized equipment will be installed, tested and the Hemp Lab is expected to become operational by the end of the year. "The Company has invested heavily in the design of its customized equipment to provide maximum capacity and efficiency. We believe that the time and capital invested in the R&D of the facility will provide much larger returns for shareholders in the future,” commented Mr. Brayden Sutton, President and CEO. Mr. Chris Rebentisch, USA COO and Founder of Infused MFG added, “The Hemp Lab will not only have the ability to process CBD, but it will also have the flexibility to isolate cannabinoids that are emerging in popularity and uses such as CBN and CBG, at commercial scale volumes. Our intention for this new vertical is to utilize all isolates in the manufacturing of our own proprietary consumer branded goods, securing the supply of raw materials, increasing our margins and benefiting from a recurring revenue stream from the sale to other manufacturers”. About 1933 Industries Inc. 1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of Alternative Medicine Association and 100% of both Infused MFG. and Spire Global Strategy.

Ja genau

kommt wieder Bewegung rein!?